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Introduction
Meta-analysis is a statistical technique for combining results from multiple independent studies, usually to estimate one overall effect with increased precision (Deeks, Altman, and Bradburn 2001) . Stata has various tools for performing meta-analysis, many of which are described in a previous collection of articles (Sterne 2009 ). These have focused on the pooling of study results in the form of aggregate (published summary) data (AD)-traditionally the most common form of meta-analysis. However, individual participant (or patient) data (IPD) are increasingly used and permit a greater range of possible analyses while minimizing bias from heterogeneity of analysis protocols between studies (for example, patient exclusions or the precise model used) and maximizing data completeness and follow-up (Stewart and Tierney 2002) .
Both "one-stage" and "two-stage" approaches exist for analyzing IPD; both are commonly used and are consistent estimators of the pooled effect. Although a one-stage estimator is always at least as efficient as its equivalent two-stage estimator for linear models where the full covariance matrix is directly observed (Mathew and Nordström 2010) , it remains unclear whether this holds for nonlinear outcomes (for example, time-to-event) and situations where the covariate matrix is only an estimate. Moreover, it is unclear whether such differences are great enough to be statistically or clinically relevant. For instance, simulation studies (Tudur Smith and Williamson 2007; Bowden et al. 2011) and case studies (Stewart et al. 2012) have shown little or no differences between onestage and two-stage models under specific conditions. Furthermore, for situations such as random-effects analysis of time-to-event data, one-stage solutions are just becoming available (Bowden et al. 2011; Crowther, Look, and Riley 2014) . Partly for this reason, the most common approach used with time-to-event data is the two-stage approach (Simmonds et al. 2005) .
In practice, the two-stage approach is appealing in its simplicity and because it can call on extensive AD meta-analysis literature, including the Cochrane Handbook (Higgins and Green 2011) . Two-stage models can offer quick and unbiased answers, especially for reviews of randomized controlled trials (RCTs), where studies are wholly independent and confounding is minimized. Also, for some situations, a one-stage model would require innovative techniques. Furthermore, studies without IPD available may be included as a sensitivity analysis (Riley et al. 2008 ) by simply including AD from publications and by using secondary requests for additional data (for example, an effect estimate adjusted for extra covariates) after an initial request for IPD has failed. Nevertheless, two-stage IPD analysis in Stata has not previously been straightforward. Now, ipdmetan provides a comprehensive two-stage package.
One motivation for collecting IPD is the possibility of assessing differential responses to treatment-in other words, of analyzing treatment-covariate interactions. In previous work (Fisher et al. 2011 ), we discussed the fundamentally different approaches to the analysis of such data and concluded that a two-stage approach is again suitable in many situations, especially compared with older methods. In future work, we hope to expand on those suggestions and discuss how trialists might facilitate meta-analysis of interactions, even if they are unwilling or unable to provide IPD, by presenting subgroup analyses clearly and consistently and thus allowing aggregate estimates to be calculated.
The standard method of presenting meta-analysis results is a forest plot, in which the results from each study are plotted together with the overall result. Previous Stata AD meta-analysis commands produce forest plots as standard, and such plots transfer naturally to two-stage IPD analysis. Results from one-stage models may also be plotted in this way, but with greater complications. The ipdforest command (Kontopantelis and Reeves 2013) is one approach to this; another might be to present two-stage study results alongside a one-stage pooled result. Forest plots for ipdmetan are created using code based heavily on that written for the metan command (Harris et al. 2008 ) but modified and updated for increased flexibility. They are produced by the program forestplot, which is called by ipdmetan but can also be run by itself, giving the user more control.
Finally, the ipdmetan package also includes the following "wrapper" programs, which I do not describe in detail here: admetan, an AD routine similar to metan; petometan, a routine for performing IPD meta-analysis of time-to-event data using the Peto logrank approach (Yusuf et al. 1985) ; and ipdover, a routine that creates forest plots of subgroups within one trial.
2 Two-stage IPD meta-analysis
Basic principles
Two-stage meta-analysis methodology involves first fitting the desired model to the data from each study in turn. This gives study-effect estimates and variances, which are denoted here by θ i and σ 2 i , respectively. These are assumed to be observed without error in the second (pooling) stage. Let θ denote the true pooled effect to be estimated by θ. A suitable reference for most of what follows is Deeks, Altman, and Bradburn (2001) , with extra references given where appropriate.
ipdmetan uses inverse-variance weighting, with weights denoted by w i = 1/σ 2 i . The Peto (or log-rank) method for time-to-event outcomes is equivalent to an inversevariance analysis, and it can be performed using ipdmetan as described in section 4.5. The built-in commands cc or tabodds can be used to perform IPD meta-analysis with Mantel-Haenszel weighting for binary outcomes.
The fixed-effects inverse-variance weighted pooled effect and its variance are calculated as
The standard Cochran heterogeneity statistic Q is defined as
and is distributed as chi-squared with k − 1 degrees of freedom (d.f.), where k is the number of included studies.
Given an estimate of between-study variance τ 2 , the random-effects inverse-variance weighted pooled effect (and variance) is calculated by replacing the fixed-effects weights w i with random-effects weights w If τ 2 = τ 2 DL , then the algebra may be rearranged to form the alternative formula
where d.f. = k − 1 is the number of d.f. associated with Q (as defined in section 2.1). is the more well known of the two and is readily interpretable on the percentage scale. However, it is a nonlinear function of τ 2 , such that an increase from, say, 80% to 90% implies a far greater increase in τ 2 than an increase from 20% to 30%. H 2 M does not have this limitation and is also less affected by the value of k, but it is perhaps less readily interpretable.
Random-effects methods
In this section, I describe the random-effects models currently available within the ipdmetan command.
Noniterative τ 2 estimators
The noniterative formulas for τ 2 presented in table 1 are based on moment-based approximations to the expectation of Q (DerSimonian-Laird; Hedges), a reparameterization of the total variance of θ i (Sidik-Jonkman), or Bayesian considerations (Rukhin) . Estimates of τ 2 are typically truncated at zero, but the Sidik-Jonkman and Rukhin bp estimators are always positive. 
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where w i = {(σ 
where N is the total number of participants within the k included studies 
where C is a critical value, as follows:
Upper confidence limit C = χ 
Confidence limits for τ 2 obtained by likelihood profiling
PL
Hardy and τ 2 same as for ML. Thompson (1996) Confidence limits for θ obtained by nested likelihood profiling
Extensions to the DerSimonian-Laird model a. Hartung-Knapp variance estimator This approach, proposed by Hartung and Knapp (2001) and independently by Sidik and Jonkman (2002) , uses an alternative estimator of Var( θ) to give improved coverage probability in the presence of between-study heterogeneity rather than relying on accurate estimation of τ 2 . Given standard DerSimonian-Laird random-effects weights w * i = 1/(σ 2 i + τ 2 DL ) and corresponding pooled effect θ * , the Hartung-Knapp variance estimator is defined as
This is used to construct the following t-based (1 − α) confidence interval for θ * :
Kontopantelis, Springate, and Reeves (2013) more recently suggested a simple nonparametric bootstrap version of DerSimonian-Laird by sampling studies with replacement and taking the mean of the truncated τ 2 DL estimates. This is intended to increase the chance of detecting heterogeneity when the true value of τ 2 is small.
Various simulation studies have been performed to assess the properties of the estimators of θ and τ 2 described above. Kontopantelis and Reeves (2012) concluded that the PL and Hartung-Knapp methods gave the most accurate coverage probabilities for θ, even when the true study effects were extremely nonnormally distributed. However, confidence intervals may be too wide for small numbers of studies k; in this situation, they recommend the standard DerSimonian-Laird method. Rukhin (2013) and Kontopantelis, Springate, and Reeves (2013) found that the Bayes estimator τ 2 BP gave reliable coverage and accurate confidence intervals for small k, except when the true heterogeneity was also small, in which case the bootstrapped DerSimonian-Laird estimator was preferable.
In terms of τ 2 , Sidik and Jonkman (2007) concluded that τ 2 GQ and τ 2 SJ were the least biased point estimates of τ 2 . Viechtbauer (2007) found that the generalized Q and approximate gamma models gave the most accurate confidence intervals for τ 2 .
Kontopantelis, Springate, and Reeves (2013) examined real-life meta-analysis data from the Cochrane Collaboration and concluded that heterogeneity is often underestimated, especially for small k. They therefore propose that sensitivity analyses be performed at specified levels of heterogeneity. Such a level might be moderate to high to test the sensitivity of conclusions regarding θ, or it may be minimal to simply force nonzero heterogeneity (see the isq() suboption to re() in section 3.2).
Interactions
What initially motivated the development of ipdmetan was unbiased estimation of patient-level treatment-covariate interactions in IPD meta-analysis. As discussed in Fisher et al. (2011) , additional complexities exist for IPD that do not occur with AD. With AD, there is just one observation per study; hence, only "study-level" characteristics can be recorded-data such as year of publication, specifics of treatment, or study-average patient characteristics. Such data can be used only to investigate how characteristics of studies may affect study-aggregate treatment effects via techniques such as meta-regression and study-subgroup analysis. However, to investigate how treatment effects differ at the patient level requires IPD. An AD analysis of study-average patient characteristics (for example, mean age or proportion male) is at risk of bias as an estimate of the true patient-level interaction effect.
Patient-level characteristics are often categorical-for example, they may be categorized by sex, age subgroups, or disease stage. It may be tempting to compare bysubgroup treatment effects to estimate an interaction. However, this is again biased if interpreted as a measure of treatment-effect difference between patients (Fisher et al. 2011) . Instead, treatment-covariate interactions must be estimated within each study separately and pooled thereafter in the same way as overall treatment effects. (Of course, continuous patient-level characteristics do not present such issues.) Assume a series of linear regressions (extension to generalized linear models or timeto-event regressions is straightforward) on patients j within studies i as follows (the parentheses around i highlight the two-stage nature of the analysis):
y is the outcome; x the treatment; z the covariate; and α, β, γ, and δ represent study, treatment, covariate, and interaction effect coefficients, respectively. We equate the interaction-effect estimates δ (i) with the study estimates θ i in section 2.1 and proceed accordingly (Simmonds and Higgins 2007; Fisher et al. 2011, Appendix B) . Such models may be extended to include adjustment for (within-study) covariates.
Interaction models are often complex, and the two-stage approach is suitable for only simple cases-principally meta-analyses of RCTs where other factors may be assumed to be balanced. Furthermore, only one coefficient may be pooled, placing limitations on variable transformation (for example, use of fractional polynomials [Royston and Altman 1994] ) and precluding the recovery of absolute effects. However, they are certain to be free of bias from between-study effects (Simmonds et al. 2005; Fisher et al. 2011, Appendix B) and to provide a quick and accurate estimate of the within-study interaction effect size. Although one-stage models permit a far greater variety of random effects, which may increase efficiency, the resulting coefficients must be interpreted carefully to ensure the intended question is answered. where estimation command is the model to be fit within each study. Typically, this will be a built-in command that changes the contents of e(b), but it could be any command that returns an effect size and standard error (or statistics that may be combined to form such). if, in, and weights should be supplied to estimation command rather than to ipdmetan (that is, after the colon rather than before it). Relevant declarations of data structure (for example, stset, tsset, and xtset) must be done before running ipdmetan.
When estimation command does not change the contents of e(b), expressions that evaluate the effect size and standard error to be collected and pooled must be specified manually by using exp list. (An optional third statistic is the number of observations.) Otherwise, exp list defaults to b[varname] se [varname] , where varname is the first independent variable within estimation command.
Options
The options in this section (supplied directly to ipdmetan) control aspects of model fitting, computation, creation of the results set, on-screen tabulation of results, and saved statistics. Some options included are relevant to the forest plot, but they are used within the main routine of ipdmetan. The only suboptions that should be supplied to the forestplot() option are those controlling graphical presentation of the results set outputted by ipdmetan. study(study id , missing ) specifies the variable that contains the study identifier, which must be either integer valued or string. study() is required.
missing requests that missing values be treated as potential study identifiers (the default is to exclude them).
by(subgroup id , missing ) specifies a variable identifying subgroups of studies (and must therefore be constant within studies), which must be integer valued or string.
If an AD dataset is specified and contains a variable named subgroup id, subgrouping will be extended to the AD observations. missing requests that missing values be treated as potential subgroup identifiers (the default is to exclude them).
eform option (see [R] eform option) specifies that effect sizes and confidence limits be exponentiated in the output (table and forest plot) and generates a heading for the effect-size column.
Note that ipdmetan does not check the validity of the particular eform option; for example, it does not check whether estimation command is a survival model if hr is supplied.
effect(string) specifies a heading for the effect-size column, overriding any heading generated by eform option.
interaction specifies that estimation command contain one or more interaction effects expressed using factor-variable syntax (see [U] 11.4.3 Factor variables) and that the first valid interaction effect be pooled across studies. This is a helpful shortcut for simple interaction analyses, but it is not foolproof or comprehensive. The output should be checked and, if necessary, the analysis rerun with the poolvar() option.
keepall specifies that all values of study id be visible in the output (table and forest  plot) , even if no effect could be estimated (for example, because of insufficient observations or missing data). For such studies, (Insufficient data) will appear in place of effect estimates and weights.
messages requests that information be printed to screen whether the effect size and standard-error statistics have been successfully obtained from each study and, if applicable, whether the iterative random-effects calculations converged successfully.
nograph and notable suppress construction of the forest plot and the table of effect sizes, respectively.
nohet suppresses all heterogeneity statistics.
nooverall suppresses the overall pooled effect so that, for instance, subgroups are considered independently. It also suppresses between-subgroup heterogeneity statistics (if applicable).
nosubgroup suppresses the within-subgroup pooled effects (if applicable) so that subgroups are displayed separately but with a single overall pooled effect with associated heterogeneity statistics.
nototal requests that estimation command not be fit within the entire dataset, for example, for time-saving reasons. By default, such fitting is done to check for problems in convergence and in the validity of requested coefficients and returned expressions. If nototal is specified, either poolvar() or exp list must be supplied, and a message appears above the dl specifies the DerSimonian-Laird estimator (equivalent to specifying re alone, with no suboption); this is the default.
dlt or hk specifies the DerSimonian-Laird with Hartung-Knapp t-based variance estimator.
bdl or dlb specifies the bootstrapped DerSimonian-Laird estimator.
ca, he, or vc specifies the Hedges variance-component estimator, also known as the Cochran estimator.
sj specifies the Sidik-Jonkman two-step estimator.
b0 and bp specify Rukhin's B0 and BP estimators, respectively. bs, bt, or gamma specifies the Biggerstaff-Tweedie approximate gamma model. eb, gq, genq, mp, or q specifies the empirical Bayes estimator, also known as the generalized Q estimator and the Mandel-Paule estimator.
ml specifies the ML estimator.
pl specifies the PL model.
reml specifies the REML estimator.
sa , isq(real ) specifies the sensitivity analysis with a fixed user-specified value of I 2 (between 0 and 1, with default isq(0.8)). See Kontopantelis, Springate, and Reeves (2013).
Note that the approximate gamma, generalized Q, ML, PL, and REML models require the mm root() function; and the bootstrapped DerSimonian-Laird model requires the mm bs() and mm jk() functions from the moremata package (ssc install moremata) (Jann 2005) . The approximate gamma model also requires the integrate command (ssc install integrate) (Mander 2012) . sortby(varname | n) allows user-specified ordering of studies in the table and forest plot. The default ordering is by study id. Note that sortby() does not alter the data in memory.
Specify sortby( n) to order the studies by their first appearance in the data by using the current sort order.
lcols(cols info) and rcols(cols info) define columns of additional data to be presented to the left or right of the forest plot. These options are carried over from metan; however, for IPD, they must first be generated from the existing dataset and thus require more complex syntax.
cols info has the following syntax, which is based on that of collapse (see [D] collapse),
where stat is as defined for collapse; newname is an optional user-specified variable name; item is either a numeric expression (in parentheses) involving returned quantities from estimation command or a variable currently in memory; %fmt is an optional format; and "label " is an optional variable label. An example using these options is in section 4.5.
plotid(varname | BYAD , list nograph ) specifies one or more categorical variables to form a series of groups of observations in which specific aspects of plot rendition may be affected using plot # opts (see Forest plot suboptions). The groups of observations will automatically be assigned ordinal labels (1, 2, . . .) on the basis of the ordering of varlist. Note that plotid() does not alter the data in memory.
ovstat(q) displays Q statistics instead of I-squared statistics.
saving(filename , replace stacklabel ) saves the forest plot "results set" (see section 4.6) created by ipdmetan in a dataset for further use or manipulation.
replace overwrites filename.
stacklabel takes the variable label from the leftmost column variable (usually study id), which would usually appear outside the plot region as the column heading, and copies it into a new first row in filename. This allows multiple such datasets to be appended without this information being overwritten.
forestplot(forestplot options) specifies other options to pass to forestplot. See Forest plot suboptions below.
The AD option
ipdmetan is designed so that IPD and AD can be analyzed together with a single command. Because of their differing structures (IPD is one observation per patient, so there are multiple observations per study; AD is one observation per study), AD must be stored in a separate Stata dataset.
The syntax for the ad() option is as follows:
where filename is an existing Stata dataset containing the AD.
vars(namelist) contains the names of variables (within filename) containing the effect size and either a standard error or lower and upper 95% confidence limits on the linear scale. If confidence limits are supplied, they must be derived from a normal distribution, or the pooled result will be incorrect (see help admetan).
It is assumed that a study identifier variable exists with the same name as in the data currently in memory (that is, the IPD). If such a variable cannot be found, studies in the AD dataset are numbered sequentially, following the largest study identifier value used for the IPD. Subgroup variables may also be present in the AD dataset and may be referenced using the main by() option.
ad options can be the following:
byad specifies that IPD and AD be treated as subgroups rather than as a single set of estimates.
npts(varname) allows participant numbers (stored in varname within filename) to be displayed in tables and forest plots.
Forest plot suboptions
Most of the forest plot options for metan can be supplied to ipdmetan via the option forestplot(), together with most appropriate [G-3] twoway options. The most significant extension that ipdmetan brings is the ability to apply specific plot rendition options (color, line patterns, etc.) to specific groups of observations via the plotid() option (see above).
The syntax for these options is plot # opts(plot options)
where plot refers to the plot feature, which can be box, ci, diam, oline, point, pci, or ppoint; # is the (optional) observation group identifier assigned by plotid(); and plot options are [G-3] twoway options appropriate to the plot type used to construct the feature, as described in Harris et al. (2008) .
The extra plot features pci and ppoint, not included in metan, are used when pooled estimates must be represented by (differently rendered) point estimates and confidence intervals instead of by diamonds. See the forestplot documentation for more details.
Stored results
ipdmetan stores the following in r() (with some variation): Scalars r(tsq var) estimated variance of tau-squared r(tsq lci) lower confidence limit for tau-squared r(tsq uci) upper confidence limit for tau-squared r(rc tausq) convergence of tau-squared point estimate r(rc tsq lci) convergence of tau-squared lower confidence limit r(rc tsq uci) convergence of tau-squared upper confidence limit r(rc eff lci) convergence of effect-size lower confidence limit r(rc eff uci) convergence of effect-size upper confidence limit
Example
The motivating example is an IPD meta-analysis of RCTs evaluating the effectiveness of postoperative radiotherapy in patients with completely resected nonsmall cell lung cancer (Burdett, Stewart, and PORT Meta-analysis Group 2005; Burdett et al. 2013 ). The outcome measure in each trial is overall survival, that is, censored time to death from any cause. A number of covariate measurements were also available but not necessarily for all trials or patients.
For an example dataset to be made publicly available, a simulated dataset was generated with similar characteristics to the postoperative radiotherapy data. It is this simulated dataset that will be discussed henceforth. There are 10 trials of varying size in 2 trial subgroups with arbitrary names. Sex, age, and disease-stage covariates have also been generated.
Basic use
Our first example aims to cover various aspects of inverse-variance meta-analysis simultaneously, because none of this functionality is particularly complex. We perform a meta-analysis of main treatment effects fit from Cox models stratified by sex, pooling the log hazard-ratios using the fixed-effects inverse-variance method.
. use ipdmetan_example . quietly stset tcens, fail(fail) . ipdmetan, study(trialid) hr by(region) > forest(favours (Favours treatment # Favours control) The command stcox trt, strata(sex) was first fit consecutively to each level of trialid. The resulting log hazard-ratios and standard errors b[trt] and se [trt] are displayed in the table and forest plot (figure 1). Specifying the eform option hr exponentiated the estimates into hazard ratios, while the by() option gave us withinsubgroup pooled estimates and tests of heterogeneity within and between subgroups and overall. The form of the rest of the output and the forest plot should be familiar to users of metan (Harris et al. 2008) . 
Treatment-covariate interactions
The syntax of ipdmetan allows any (single) estimated quantity and its standard error to be pooled across studies. This includes simple interaction models of the form given in section 2.3. Specifying the interaction option tells ipdmetan to identify and pool the treatment-covariate interaction coefficient and to use different symbols and effectsize column headings on the forest plot to differentiate such analyses from those of main effects. (Note that all of this behavior can be reproduced manually using other options.)
Studies often have insufficient covariate data, and such studies will be excluded from the corresponding interaction analysis. The default is to remove excluded studies from the output. However, this can be overridden with the keepall option, which will instead output "(Insufficient data)" for such studies in place of the effect size, the standard error, and the weighting in both table and forest plot. (This option applies generally. I mention it here because it is likely to have greater relevance.)
The screen output has only minor differences from that of a main-effects analysis, so we show only the forest plot here (figure 2). The default for interaction analyses is to use solid circles for the study effects and a clear circle for the pooled effect.
. ipdmetan, study(trialid) interaction hr keepall forest(favours("Favours > greater treatment effect" "with higher disease stage" > # "Favours greater treatment effect" "with lower disease stage") > boxsca (200) fp (1) 
Random effects
We now show the syntax and output of the random-effects options. DerSimonian-Laird, the most common random-effects model, is specified with "re".
• Saved datasets have a standard format where the study variable is named STUDY.
Therefore, we change our trialid variable to match (using clonevar) and so obtain correct labels throughout.
• We restrict the ad() option to USE==1 so that only individual study estimates are included and not the pooled estimate.
. quietly ipdmetan, study(trialid) hr nograph saving(region2. The numerical output is the same as in our first example, as expected. Note that to treat the IPD and AD as two subgroups, we specified the byad option; this also labels the subgroups appropriately in both the table and forest plot (not shown). The nooverall option requests that the table and forest plot present IPD and AD separately and not present an "overall" pooled result. This will also present weights and effect lines by subgroup rather than overall. Above the table, the number of trials and patients are also given separately for IPD and for AD. If the number of patients is missing for one or more observations in the AD dataset, ipdmetan will output a missing value here.
Further functionality
In this section, I discuss a few more useful features of ipdmetan and forestplot. For this next example, we return to the original analysis in section 4.1, but instead of Cox regression, we will use the noniterative Peto log-rank method. This is based on the log-rank test done by sts test, but it requires values stored in the vector u and matrix V (see documentation of the mat() option in [ST] sts test) to estimate the effect size (log hazard-ratio) and standard error for each trial. Therefore, we must supply ipdmetan with appropriate expressions for these quantities as an exp list. Using our current example, we also demonstrate the use of lcols() and rcols() by presenting the O − E and V statistics (Yusuf et al. 1985) , and we demonstrate the use of plot # opts by rendering the weighted boxes and confidence interval lines in a light shade for the European trials (with capped confidence intervals) and in a darker shade for the North American trials. We proceed as follows (see figure 3) : For the right-hand columns, we have requested that the usual statistics and weights be suppressed (options nostats and nowt) and replaced with the observed minusexpected event count and variance of observed event count (stored by sts test in u[1,1] and V[1,1], respectively). Following each statistic is an (optional) format and column heading. (Note that this plot may be re-created with a Peto log-rank metaanalysis by using petometan, which is part of the ipdmetan package.) Forest plots, with their columns of text and numbers, are unnatural to Stata, and sometimes, plots produced by ipdmetan or forestplot may be deficient in appearance (text too small or overlapping, too much white space, etc.). There are many options available that can correct such deficiencies (see the help file).
Use of results sets
Within a two-stage framework, IPD and AD may be considered a "long form" and "short form" of the same data. It may be useful to convert IPD to AD to perform certain tasks. This can be accomplished by using the saving() option with ipdmetan (see section 3.2), which saves an AD results set in a format suitable for forestplot. Hence, running forestplot on the results set will give the same plot as running ipdmetan on the original data.
As an example, the results set outputted by the analysis in section 4.1 is shown in the table below (value labels not displayed). This format includes not only the study estimates but also the pooled estimates with extra lines for subgroup headings and heterogeneity descriptions and blank lines for spacing. The values of the variable USE specify the function of each observation, while text (study names, headings, etc., excluding extra data specified in lcols() and rcols()) is stored in the variable LABELS.
Possible uses of such results sets include the following:
• Restricting the results set to observations for which USE==1 (that is, the individual study estimates) creates a standard AD dataset that can be analyzed with any AD meta-analysis command. Hence, features not yet supported by ipdmetan can be used, such as prediction intervals with metan (Harris et al. 2008) or the "permutations" model of metaan (Kontopantelis and Reeves 2010) , as well as related analyses such as meta-regression on study-level covariates (metareg, Harbord and Higgins [2008] ) or network meta-analysis (mvmeta, White [2009] ).
• If the initial stage in ipdmetan of fitting the model to each study proves time consuming, it need be performed only once. Subsequent tasks, such as investigating random-effects models (see previous bullet) or tweaking the forest plot (see following bullet), can be done with admetan or forestplot using the results set.
• The results set contains all the information that forestplot needs to construct the plot. Therefore, the layout of the forest plot can be customized by altering the results set; for instance, it can be altered to amend labels or titles, add or remove lines, or add or format extra columns of data (to be specified with lcols() and rcols()). For example, strings of the form "n/N " can be presented, where n is the number of events and N the total number of patients.
• More complex forest plots may not be possible to create with a single call to ipdmetan. Instead, ipdmetan might be run on a series of different datasets and results saved. The standard formatting of results sets allows straightforward appending to a single dataset using append (see [D] append), potentially with the generate suboption to create a variable to pass to the plotid() suboption of forestplot() (see section 4.5). It may then be necessary to alter labels or titles (see previous bullet). 
Discussion
Meta-analysis is a widely used and constantly evolving technique that has made an enormous contribution to evidence-based policy and practice, particularly in health care. Although one-stage hierarchical models are increasingly seen and may have statistical advantages in some situations, the two-stage approach remains commonplace when IPD are available.
The ipdmetan command is a tool for performing two-stage IPD analysis simply and straightforwardly; it gives a standardized output and publication-standard forest plots (based on the original forest plot subroutine within metan). The syntax is designed to encompass varying levels of complexity, and the dedicated forestplot command allows great flexibility of presentation. The package also provides useful capabilities such as trial subgroup plots (via ipdover) and inclusion of AD.
Future work might include the ability to present prognostic effects in a forest plot with respect to a reference, as well as the ability to use multiple imputation for missing covariates using mi.
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